Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Nov 2, 2021, before the open
10-Q filed Nov 2, 2021, 33 days after period end · 0001558370-21-014043
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $1.03M | — | — | — |
| Net Income | -$35.11M | -$33.82M | -$36.00M | -$17.69M |
| EPS Diluted |
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
| -$0.70 |
| -$0.77 |
| -$1.04 |
| -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.